Robert T Means Jr, MD

MD: Vanderbilt University Nashville TN, 1983

BA (magna cum laude): Rice University Houston TX, 1979 (Biochemistry)

Internal Medicine Residency: Baylor College of Medicine Houston TX, 1986

Hematology Fellowship: Vanderbilt University Nashville TN, 1988

American Board of Internal Medicine (Hematology) (Certification Date: 11-01-1988 )

Hematology

Hematology and Oncology

Sickle Cell Anemia

Hematology

Peer Reviewed Publications

Benson, Ashley E; Lo, Jamie O; Achebe, Maureen O; Aslan, Jorgeane S; Auerbach, Michael; Bannow, Bethany T Samuelson; Boller, Marie J; Deloughery, Thomas G; Dingman, Jacquelin; Van Doren, Layla; Dy, Geolani W; Ford, Patricia A; Freed, Jason A; Georgieff, Michael K; Haley, Kristina M; Han, Chloe I; Lewkowitz, Adam K; Martens, Kylee L; Means, Robert T; Nemeth, Elizabeta; Olson, Sven R; Powers, Jacquelyn M; Prewitt, Kristin C; Richards, Toby; Rockey, Don C; Roeland, Eric J; Ryan, Kimberly S; Al-Samkari, Hanny; Sholzberg, Michelle; Tuuli, Methodius G; Weyand, Angela C; Zeller, Michelle P; Totten, Annette M; Ivlev, Ilya; Shatzel, Joseph J  (2025). Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations. The Lancet. Haematology, 12 (5) , e376-e388More Information

Means, Robert T; Bi, Caixia; Wong, Edward C C; Bare, Lance A; McPhaul, Michael J  (2024). Ferritin reference intervals in a population of working-age adults without anemia. American journal of hematology, 99 (10) , 2047-2049More Information

Means, Robert T  (2024). New molecular approaches to "the first molecular disease". Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 72 (6) , 495-496More Information

Means, Robert T  (2023). Pure red cell aplasia: The second hundred years. The American journal of the medical sciences, 366 (3) , 160-166More Information

Means, Robert T  (2023). Ineffective erythropoiesis and osteoporosis in thalassemia: Mechanistic insights?. The American journal of the medical sciences, 366 (2) , 85-86More Information

Al-Samkari, Hanny; Glaspy, John A; Means, Robert T; Chertow, Glenn M; Auerbach, Michael  (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of internal medicine, 175 (11) , W143More Information

Holt, Hannah D; Holt, Matthew F; Means, Robert T  (2022). Concurrent pseudothrombocytopenia and immune thrombocytopenia. The American journal of the medical sciences, 364 (3) , e31-e32More Information

Means, Robert T  (2022). New agents for sickle cell disease: patient perceptions of benefit in the real world. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 70 (5) , 1210-1211More Information

Means, Robert T  (2022). Hepcidin, iron, and COVID-19: is there an erythroid connection?. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 70 (4) , 861-862More Information

Means, Robert T  (2022). Yet another amyloidosis. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 70 (2) , 347More Information

Means, Robert T  (2022). Update on pure red cell aplasia: etiology, diagnosis, and treatment. Clinical advances in hematology & oncology : H&O, 20 (1) , 18-21

Fatima, Zainab; Reece, Blair R A; Moore, J Suzanne; Means, Robert T  (2022). Autoimmune Hemolytic Anemia After mRNA COVID Vaccine. Journal of investigative medicine high impact case reports, 10, 23247096211073258More Information

Means, Robert T  (2020). Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients, 12 (2) More Information

Means, Robert T  (2020). Lymphoma classification: morphology to molecular. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 68 (2) , 319-320More Information

McKenzie, Stacey W; Means, Robert T  (2019). Blood Cultures and Culture Change. The American journal of the medical sciences, 358 (3) , 171-172More Information

Means, Robert T  (2016). Pure red cell aplasia. Hematology. American Society of Hematology. Education Program, 2016 (1) , 51-56More Information

Means, Robert T  (2016). Pure red cell aplasia. Blood, 128 (21) , 2504-2509More Information

Means, Robert T  (2016). Desiderata: Founders' Medal Award Acceptance. The American journal of the medical sciences, 352 (1) , 9-10More Information

Means, Robert T  (2016). The Greatest Hematologist in the World. The American journal of the medical sciences, 351 (3) , 323-4More Information

Means, Robert T  (2015). ACP Journal Club. Review: I.v. iron does not increase serious adverse events compared with other forms of iron. Annals of internal medicine, 162 (10) , JC8More Information

Means, Robert T  (2015). Hepcidin in differential diagnosis: ready for the clinic?. European journal of haematology, 94 (1) , 2-3More Information

Means, Robert T  (2013). Iron metabolism: bedside to bench and back. The American journal of the medical sciences, 346 (5) , 402More Information

Means, Robert T  (2013). Anemia of inflammation: clinical insights from mechanisms. [Rinsho ketsueki] The Japanese journal of clinical hematology, 54 (10) , 1596-602

Means, Robert T  (2013). Iron deficiency anemia. Hematology (Amsterdam, Netherlands), 18 (5) , 305-6More Information

Means, Robert T  (2013). Continuing adventures. The American journal of the medical sciences, 346 (1) , 1-2More Information

Christopher, K L; Wiggins, A T; Van Meter, E M; Means, R T; Hayslip, J W; Roach, J P  (2013). Differences in vitamin D nutritional status between newly diagnosed cancer patients from rural or urban settings in Kentucky. Nutrition and cancer, 65 (5) , 653-8More Information

Means, Robert T  (2013). Hepcidin and iron regulation in health and disease. The American journal of the medical sciences, 345 (1) , 57-60More Information

Wilson, Bethany; Means, Robert T  (2011). Acquired factor VIII inhibitor as initial manifestation of collagen vascular disease: response to combination immunosuppression as first-line therapy. The American journal of the medical sciences, 342 (1) , 70-2More Information

Means, Robert T  (2011). Free and easy? Red cell distribution width (RDW) and prognosis in cardiac disease. Journal of cardiac failure, 17 (4) , 299-300More Information

Means, Robert T  (2011). It all started in New Orleans: Wintrobe, the hematocrit and the definition of normal. The American journal of the medical sciences, 341 (1) , 64-5More Information

Means, Robert T  (2010). JAK2 V617F and the evolving paradigm of polycythemia vera. The Korean journal of hematology, 45 (2) , 90-4More Information

Means, Robert T; Moliterno, David J; Allison, G Roxanne; Perman, Jay A; Lofgren, Richard P; Karpf, Michael; Debeer, Frederick C  (2010). The evolution of a Department of Internal Medicine under an integrated clinical enterprise model: the University of Kentucky experience. Academic medicine : journal of the Association of American Medical Colleges, 85 (3) , 531-7More Information

Means, Robert T  (2009). Higher red blood cell distribution width was associated with increased risk of mortality in adults > or =45 years of age. Evidence-based medicine, 14 (5) , 151More Information

Means, Robert T  (2009). Ironing out complementary medicine. Blood, 113 (2) , 270-1More Information

Dallalio, Gail; Means, Robert T  (2008). Placental growth factor attenuates suppression of erythroid colony formation by interferon. Translational research : the journal of laboratory and clinical medicine, 152 (5) , 233-8More Information

Means, Robert T  (2008). JAK2 V617F mutation testing in polycythemia vera: use and impact in an academic practice. The American journal of the medical sciences, 336 (4) , 327-9More Information

Means, Robert T  (2008). Perspective: Osler's 1903 paper on polycythemia vera. The American journal of the medical sciences, 335 (6) , 418-9More Information

Dallalio, Gail; Brunson, Chris Y; Means, Robert T  (2007). Cytokine concentrations in bone marrow of stable sickle cell anemia patients. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 55 (2) , 69-74More Information

Dallalio, Gail; Law, Erin; Means, Robert T  (2006). Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood, 107 (7) , 2702-4More Information

Masimasi, Nziavake; Means, Robert T  (2005). Elevated troponin levels associated with hemolysis. The American journal of the medical sciences, 330 (4) , 201-3More Information

Means, Robert T  (2004). Hepcidin and anaemia. Blood reviews, 18 (4) , 219-25More Information

Means, Robert T  (2004). Hepcidin and cytokines in anaemia. Hematology (Amsterdam, Netherlands), 9 (5-6) , 357-62More Information

Dallalio, Gail; Fleury, Thomas; Means, Robert T  (2003). Serum hepcidin in clinical specimens. British journal of haematology, 122 (6) , 996-1000More Information

Dallalio, Gail; Means, Robert T  (2003). Effects of oxidative stress on human erythroid colony formation: Modulation by gamma-interferon. The Journal of laboratory and clinical medicine, 141 (6) , 395-400More Information

Means, Robert T  (2003). Recent developments in the anemia of chronic disease. Current hematology reports, 2 (2) , 116-21

Van Laer, A; Dallalio, Gail; McKenzie, Stacey W; Means, Robert T  (2002). Thioredoxin and protein nitrotyrosine in bone marrow supernatant from patients with human immunodeficiency virus infection. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 50 (1) , 10-8

Pollak, V E; Lorch, J A; Means, R T  (2001). Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 49 (2) , 173-83More Information

Means, R T  (2000). The anaemia of infection. Bailliere's best practice & research. Clinical haematology, 13 (2) , 151-62More Information

Dallalio, G; North, M; McKenzie, S W; Means, R T  (1999). Cytokine and cytokine receptor concentrations in bone marrow supernatant from patients with HIV: correlation with hematologic parameters. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 47 (9) , 477-83

Mendenhall, C L; Finkelman, F; Means, R T; Sherman, K E; Nguyen, V T; Grossman, C E; Morris, S C; Rouster, S; Roselle, G A  (1999). Cytokine response to BCG infection in alcohol-fed mice. Alcohol (Fayetteville, N.Y.), 19 (1) , 57-63More Information

Means, R T  (1999). Advances in the anemia of chronic disease. International journal of hematology, 70 (1) , 7-12

Dallalio, G; North, M; Worden, B D; Means, R T  (1999). Inhibition of human erythroid colony formation by ceramide. Experimental hematology, 27 (7) , 1133-8More Information

Means, R T; Allen, J; Sears, D A; Schuster, S J  (1999). Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients. Clinical and laboratory haematology, 21 (3) , 161-7More Information

Means, R T  (1999). Commentary: an anemia of chronic disease, after all?. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 47 (5) , 203

Means, R T  (1999). Neocytolysis: from outer space to the dialysis unit. American journal of kidney diseases : the official journal of the National Kidney Foundation, 33 (1) , 140-1More Information

Wani, M A; Means, R T; Lingrel, J B  (1998). Loss of LKLF function results in embryonic lethality in mice. Transgenic research, 7 (4) , 229-38More Information

Allen, J; Backstrom, K R; Cooper, J A; Cooper, M C; Detwiler, T C; Essex, D W; Fritz, R P; Means, R T; Meier, P B; Pearlman, S R; Roitman-Johnson, B; Seligman, P A  (1998). Measurement of soluble transferrin receptor in serum of healthy adults. Clinical chemistry, 44 (1) , 35-9

Means, R T  (1997). Cytokines and anaemia in human immunodeficiency virus infection. Cytokines, cellular & molecular therapy, 3 (3) , 179-86

North, M; Dallalio, G; Donath, A S; Melink, R; Means, R T  (1997). Serum transferrin receptor levels in patients undergoing evaluation of iron stores: correlation with other parameters and observed versus predicted results. Clinical and laboratory haematology, 19 (2) , 93-7More Information

McKenzie, S W; Means, R T  (1997). Extreme hyperferritinemia in patients infected with human immunodeficiency virus is not a highly specific marker for disseminated histoplasmosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 24 (3) , 519-20More Information

Dallalio, G; North, M; Means, R T  (1996). Inhibition of marrow CFU-E colony formation from human immunodeficiency virus-infected patients by beta- and gamma-interferon. American journal of hematology, 53 (2) , 118-20More Information

McKenzie, S W; Dallalio, G; North, M; Frame, P; Means, R T  (1996). Serum chemokine levels in patients with non-progressing HIV infection. AIDS (London, England), 10 (9) , F29-33More Information

Dai, W; Pan, H Q; Ouyang, B; Greenberg, J M; Means, R T; Li, B; Cardie, J  (1996). Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation. Leukemia, 10 (6) , 978-83

Means, R T; Mendenhall, C L; Worden, B D; Moritz, T E; Chedid, A  (1996). Erythropoietin and cytokine levels in the anemia of severe alcoholic liver disease. Alcoholism, clinical and experimental research, 20 (2) , 355-8More Information

Means, R T; Krantz, S B  (1996). Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. Experimental hematology, 24 (2) , 204-8

Lee, M H; Means, R T  (1995). Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. The American journal of medicine, 98 (6) , 566-71More Information

Means, R T  (1995). Erythropoietin in the treatment of anemia in chronic infectious, inflammatory, and malignant diseases. Current opinion in hematology, 2 (3) , 210-3More Information

Means, R T  (1995). Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem cells (Dayton, Ohio), 13 (1) , 32-7More Information

Stein, R S; Means, R T; Krantz, S B; Flexner, J M; Greer, J P  (1994). Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits. The American journal of the medical sciences, 308 (6) , 338-43More Information

Means, R T  (1994). Clinical application of recombinant erythropoietin in the anemia of chronic disease. Hematology/oncology clinics of North America, 8 (5) , 933-44

Means, R T; Krantz, S B; Luna, J; Marsters, S A; Ashkenazi, A  (1994). Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood, 83 (4) , 911-5

Means, R T; Krantz, S B  (1993). Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. The Journal of clinical investigation, 91 (2) , 416-9More Information

Means, R T; Sandidge, D R; Rankin, K M; Robichaux, M R  (1992). Treatment of phenothiazine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor. American journal of hematology, 41 (4) , 296More Information

Means, R T; Krantz, S B  (1992). Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 80 (7) , 1639-47

Dai, C H; Krantz, S B; Dessypris, E N; Means, R T; Horn, S T; Gilbert, H S  (1992). Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood, 80 (4) , 891-9

Means, R T; Dessypris, E N; Krantz, S B  (1992). Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. Journal of cellular physiology, 150 (1) , 59-64More Information

Means, R T; Krantz, S B  (1991). Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood, 78 (10) , 2564-7

Means, R T; Dessypris, E N; Krantz, S B  (1991). Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. British journal of haematology, 78 (1) , 114-9More Information

Cotton, E W; Means, R T; Cline, S M; Krantz, S B  (1991). Quantitation of insulin-like growth factor-I binding to highly purified human erythroid colony-forming units. Experimental hematology, 19 (4) , 278-81

Dai, C H; Krantz, S B; Means, R T; Horn, S T; Gilbert, H S  (1991). Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. The Journal of clinical investigation, 87 (2) , 391-6More Information

Means, R T; Dessypris, E N; Krantz, S B  (1990). Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. The Journal of clinical investigation, 86 (2) , 538-41More Information

Dai, C H; Krantz, S B; Means, R T; Horn, S T; Gilbert, H S  (1990). Increased sensitivity of polycythemia vera blood burst-forming units-erythroid to interleukin 3. Transactions of the Association of American Physicians, 103, 249-57

Means, R T; Krantz, S B; Sawyer, S T; Gilbert, H S  (1989). Erythropoietin receptors in polycythemia vera. The Journal of clinical investigation, 84 (4) , 1340-4More Information

Means, R T; Olsen, N J; Krantz, S B; Dessypris, E N; Graber, S E; Stone, W J; O'Neil, V L; Pincus, T  (1989). Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis and rheumatism, 32 (5) , 638-42More Information

Means, R T; McCurley, T L; Flexner, J M; Stein, R S  (1988). Plasmacytic neoplasm of the gastrointestinal tract in a patient with long-standing monoclonal gammopathy. Southern medical journal, 81 (10) , 1331-2More Information

Means, R T; Krantz, S B; Dessypris, E N; Lukens, J N; Niblack, G D; Greer, J P; Flexner, J M; Stein, R S  (1988). Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. The American journal of medicine, 84 (4) , 678-82More Information

Means R.T.  (02-01-2024). Memoriam: Sanford B. Krantz, MD 1934–2023. American Journal of the Medical Sciences, 367 (2) , 149-150More Information

Means R.T.  (01-01-2019). Nutritional Anemia: Scientific Principles, Clinical Practice, and Public Health. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 1-209More Information

Means R.T.  (01-01-2019). Impact of Anemia: Overview. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 10-15More Information

Means R.T.  (01-01-2019). Nutritional Anemia during Pregnancy. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 143-152More Information

Means R.T.  (01-01-2019). Treatment of Iron Deficiency Anemia in Adults. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 85-95More Information

Means R.T.  (01-01-2019). General Hematology of Anemia. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 1-9More Information

Means R.T.  (01-01-2019). Physiology of Copper Balance and Metabolism. Nutritional Anemia Scientific Principles Clinical Practice and Public Health, 103-110More Information

Means R.T.  (11-19-2018). Anemias during pregnancy and the postpartum period. Wintrobe S Clinical Hematology Fourteenth Edition, 3114-3133

Means R.T.  (11-19-2018). Anemias secondary to inflammation/chronic disease and systemic disorders. Wintrobe S Clinical Hematology Fourteenth Edition, 3064-3113

Means R.T.  (11-19-2018). Polycythemia vera. Wintrobe S Clinical Hematology Fourteenth Edition, 5324-5355

Means R.T.; Glader B.  (11-19-2018). Acquired nonimmune hemolytic disorders. Wintrobe S Clinical Hematology Fourteenth Edition, 2439-2474

Means R.T.; Glader B.  (11-19-2018). Erythrocytosis. Wintrobe S Clinical Hematology Fourteenth Edition, 3171-3197

Rodgers G.M.; Means R.T.  (11-19-2018). Thrombocytosis and essential thrombocythemia. Wintrobe S Clinical Hematology Fourteenth Edition, 3461-3481

Means R.T.; Glader B.  (11-19-2018). Anemia: General considerations. Wintrobe S Clinical Hematology Fourteenth Edition, 1802-1861

Quigley J.G.; Means R.T.; Glader B.  (11-19-2018). The birth, life, and death of red blood cells: Erythropoiesis, the mature red blood cell, and cell d. Wintrobe S Clinical Hematology Fourteenth Edition, 284-407

Narla A.; Lipton J.M.; Means R.T.  (11-19-2018). Red cell aplasia: Acquired and congenital disorders. Wintrobe S Clinical Hematology Fourteenth Edition, 3004-3038

Greer J.P.; Arber D.A.; Glader B.E.; List A.F.; Means R.T.; Rodgers G.M.; Appelbaum F.R.; Dispenzieri A.; Fehniger T.A.  (11-19-2018). Wintrobe's clinical hematology: Fourteenth edition. Wintrobe S Clinical Hematology Fourteenth Edition, 1-7072

Means R.T.  (11-13-2018). Introduction: Anemia at the extremes of life. Anemia in the Young and Old Diagnosis and Management, 3-7More Information

Means R.T.  (11-13-2018). Anemia in the young and old: Diagnosis and management. Anemia in the Young and Old Diagnosis and Management, 1-219More Information

Means R.T.  (11-13-2018). Pure red cell aplasia. Anemia in the Young and Old Diagnosis and Management, 167-178More Information

Means R.T.  (11-13-2018). Preface. Anemia in the Young and Old Diagnosis and Management, vii-viii

Means R.T.  (11-13-2018). Approach to anemia in the elderly. Anemia in the Young and Old Diagnosis and Management, 27-35More Information

Means R.T.  (11-13-2018). Anemia of renal failure/chronic kidney disease. Anemia in the Young and Old Diagnosis and Management, 147-156More Information

Means R.T.  (11-13-2018). The anemia of inflammation/chronic disease and the unexplained anemia of the elderly. Anemia in the Young and Old Diagnosis and Management, 157-166More Information

Means R.T.  (08-24-2016). Anemia of inflammation. Nonmalignant Hematology Expert Clinical Review Questions and Answers, 97-102More Information

Means R.T.  (08-29-2013). Anemias during pregnancy and the postpartum period. Wintrobe S Clinical Hematology Thirteenth Edition, 1012-1017

Means R.T.  (08-29-2013). Anemias secondary to chronic disease and systemic disorders. Wintrobe S Clinical Hematology Thirteenth Edition, 998-1011

Means R.T.  (08-29-2013). Erythrocytosis. Wintrobe S Clinical Hematology Thirteenth Edition, 1032-1042

Means R.T.  (08-29-2013). Polycythemia vera. Wintrobe S Clinical Hematology Thirteenth Edition, 1722-1733

Means R.T.; Glader B.  (08-29-2013). Anemia: General considerations. Wintrobe S Clinical Hematology Thirteenth Edition, 587-616

Rodgers G.M.; Means R.T.  (08-29-2013). Thrombocytosis and essential thrombocythemia. Wintrobe S Clinical Hematology Thirteenth Edition, 1122-1127

Means R.T.; Glader B.  (08-29-2013). Acquired nonimmune hemolytic disorders. Wintrobe S Clinical Hematology Thirteenth Edition, 809-822

Lipton J.M.; Glader B.; Means R.T.  (08-29-2013). Red cell aplasia: Acquired and congenital disorders. Wintrobe S Clinical Hematology Thirteenth Edition, 975-989

Quigley J.G.; Means R.T.; Glader B.  (08-29-2013). The birth, life, and death of red blood cells: Erythropoiesis, the mature red blood cell, and cell d. Wintrobe S Clinical Hematology Thirteenth Edition, 83-124

Greer J.P.; Arber D.A.; Glader B.; List A.F.; Means R.T.; Paraskevas F.; Rodgers G.M.; Foerster J.  (08-29-2013). Wintrobe's clinical hematology: Thirteenth edition. Wintrobe S Clinical Hematology Thirteenth Edition, 1-3094

Means R.  (01-01-2013). Continuing adventures. American Journal of the Medical Sciences, 346 (1) , 1-2More Information

Means R.T.  (01-01-2012). Editorial: Anything can happen and it probably will: The American Journal of the Medical Sciences. American Journal of the Medical Sciences, 343 (3) , 185More Information

Wilson B.; Means R.T.  (01-01-2011). Acquired factor viii inhibitor as initial manifestation of collagen vascular disease: Response to co. American Journal of the Medical Sciences, 342 (1) , 70-72More Information

Huang J.; Means R.  (04-29-2010). The frequency and significance of Iron-Deficiency anemia in patients with selected concurrent illnes. Internet Journal of Internal Medicine, 8 (1)

Means R.T.; Moliterno D.J.; Allison G.R.; Perman J.A.; Lofgren R.P.; Karpf M.; Debeer F.C.  (01-01-2010). The evolution of a department of internal medicine under an integrated clinical enterprise model: Th. Academic Medicine, 85 (3) , 531-537More Information

Means R.  (10-01-2009). Higher red blood cell distribution width was associated with increased risk of mortality in adults ?. Evidence Based Medicine, 14 (5) , 151More Information

Means R.T.  (10-01-2009). Monoclonal gammopathy in the natural history of multiple myeloma. American Journal of Hematology Oncology, 8 (10)

Means R.T.  (01-08-2009). Ironing out complementary medicine. Blood, 113 (2) , 270-271More Information

Means R.T.  (01-15-2006). Closing the TRAIL to the DISC. Blood, 107 (2) , 418-419More Information

Means R.  (01-01-2005). Inhibition of erythropoiesis by inflammatory cytokines. Anemia of Chronic Disease, 127-144

Means R.T.; McLaren G.D.  (01-01-2005). Anemia of chronic disease in hematologic disorders and oncology. Anemia of Chronic Disease, 593-606

North M.; Dallalio G.; Means R.; Ralph H.; Johnson V.  (12-01-1998). Effects of ceramide on human erythro1d colony formation:involvement in the inhibition induced by int. Experimental Hematology, 26 (8) , 808

Dai W.; Pan H.Q.; Ouyang B.; Greenberg J.M.; Means R.T.; Li B.; Cardie J.  (01-01-1996). Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation. Leukemia, 10 (6) , 978-983

Robertson D.; Robertson D.; Robertson D.; Robertson D.; Robertson D.; Robertson D.; Davis T.L.; Robertson D.; Onrot J.; Goldberg M.R.; Hollister A.S.; Hollister A.S.; Chobanian A.V.; Volicer L.; Tifft C.P.; Mitsky V.P.; Workman R.J.; Nicholson E.; McTavish D.; Goa K.L.; Jankovic J.; Gilden J.L.; Hiner B.C.; Keys A.; Violante A.; Means R.T.; Krantz S.B.; Krantz S.B.; Krantz S.B.; Krantz S.B.; Heans R.T.; Olsen N.J.; Bradbury S.; Eggleston C.; Biaggioni I.; Hoeldtke R.D.; Streeten D.H.; Biaggioni I.; Perry S.E.; Kincaid D.W.; Robertson R.M.  (01-01-1995). Recent advances in the treatment of orthostatic hypotension. Neurology, 45 (4) , S26-S32

Denz H.; Fuchs D.; Wachter H.; Means R.T.; Krantz S.B.  (01-01-1992). Altered iron metabolism and the anemia of chronic disease: A role of immune activation [1]. Blood, 79 (10) , 2797-2798More Information

Means R.T.  (01-01-1990). Osier’s brain. Southern Medical Journal, 83 (6) , 723More Information

Means R.T.  (01-01-1990). Osler's Brain. Southern Medical Journal, 83 (6) , 723More Information